Your browser doesn't support javascript.
loading
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.
Thorgeirsson, Thorgeir E; Geller, Frank; Sulem, Patrick; Rafnar, Thorunn; Wiste, Anna; Magnusson, Kristinn P; Manolescu, Andrei; Thorleifsson, Gudmar; Stefansson, Hreinn; Ingason, Andres; Stacey, Simon N; Bergthorsson, Jon T; Thorlacius, Steinunn; Gudmundsson, Julius; Jonsson, Thorlakur; Jakobsdottir, Margret; Saemundsdottir, Jona; Olafsdottir, Olof; Gudmundsson, Larus J; Bjornsdottir, Gyda; Kristjansson, Kristleifur; Skuladottir, Halla; Isaksson, Helgi J; Gudbjartsson, Tomas; Jones, Gregory T; Mueller, Thomas; Gottsäter, Anders; Flex, Andrea; Aben, Katja K H; de Vegt, Femmie; Mulders, Peter F A; Isla, Dolores; Vidal, Maria J; Asin, Laura; Saez, Berta; Murillo, Laura; Blondal, Thorsteinn; Kolbeinsson, Halldor; Stefansson, Jon G; Hansdottir, Ingunn; Runarsdottir, Valgerdur; Pola, Roberto; Lindblad, Bengt; van Rij, Andre M; Dieplinger, Benjamin; Haltmayer, Meinhard; Mayordomo, Jose I; Kiemeney, Lambertus A; Matthiasson, Stefan E; Oskarsson, Hogni.
Afiliación
  • Thorgeirsson TE; deCODE Genetics, Reykjavik Iceland.
  • Geller F; deCODE Genetics, Reykjavik Iceland.
  • Sulem P; deCODE Genetics, Reykjavik Iceland.
  • Rafnar T; deCODE Genetics, Reykjavik Iceland.
  • Wiste A; deCODE Genetics, Reykjavik Iceland.
  • Magnusson KP; Emory University, Department of Psychiatry and Behavioral Sciences, Atlanta, GA US.
  • Manolescu A; deCODE Genetics, Reykjavik Iceland.
  • Thorleifsson G; deCODE Genetics, Reykjavik Iceland.
  • Stefansson H; deCODE Genetics, Reykjavik Iceland.
  • Ingason A; deCODE Genetics, Reykjavik Iceland.
  • Stacey SN; deCODE Genetics, Reykjavik Iceland.
  • Bergthorsson JT; deCODE Genetics, Reykjavik Iceland.
  • Thorlacius S; deCODE Genetics, Reykjavik Iceland.
  • Gudmundsson J; deCODE Genetics, Reykjavik Iceland.
  • Jonsson T; deCODE Genetics, Reykjavik Iceland.
  • Jakobsdottir M; deCODE Genetics, Reykjavik Iceland.
  • Saemundsdottir J; deCODE Genetics, Reykjavik Iceland.
  • Olafsdottir O; deCODE Genetics, Reykjavik Iceland.
  • Gudmundsson LJ; deCODE Genetics, Reykjavik Iceland.
  • Bjornsdottir G; deCODE Genetics, Reykjavik Iceland.
  • Kristjansson K; deCODE Genetics, Reykjavik Iceland.
  • Skuladottir H; deCODE Genetics, Reykjavik Iceland.
  • Isaksson HJ; Landspitali University Hospital, Department of Medical Oncology, Reykjavik Iceland.
  • Gudbjartsson T; Landspitali University Hospital, Department of Pathology, Reykjavik Iceland.
  • Jones GT; Landspitali University Hospital, Department of Cardiothoracic Surgery, Reykjavik Iceland.
  • Mueller T; Department of Surgery, Dunedin School of Medicine, University of Otago, New Zealand.
  • Gottsäter A; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
  • Flex A; Center for Vascular Diseases, University Hospital. MAS, Malmö, Sweden.
  • Aben KKH; Laboratory of Vascular Biology & Genetics, A. Gemelli University Hospital,Universita Cattolica del Sacro Cuore School of Medicine, Rome, Italy.
  • de Vegt F; Radboud University Nijmegen Medical Centre, Department of Epidemiology & Biostatistics, Nijmegen, Netherlands.
  • Mulders PFA; Comprehensive Cancer Center East, Nijmegen, Netherlands.
  • Isla D; Radboud University Nijmegen Medical Centre, Department of Epidemiology & Biostatistics, Nijmegen, Netherlands.
  • Vidal MJ; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, Netherlands.
  • Asin L; University Hospital, Division of Medical Oncology, Zaragoza Spain.
  • Saez B; University Hospital, Division of Medical Oncology, Zaragoza Spain.
  • Murillo L; Nanotechnology Institute of Aragon, Zaragoza Spain.
  • Blondal T; Health Science Institute, Zaragoza Spain.
  • Kolbeinsson H; Hospital Reina Sofia, Division of Medical Oncology, Tudela Spain.
  • Stefansson JG; Reykjavik Primary Health Care Centre, Department of Lung Disease, Reykjavik Iceland.
  • Hansdottir I; Landspitali University Hospital, Department of General Adult Psychiatry, Reykjavik Iceland.
  • Runarsdottir V; Landspitali University Hospital, Department of General Adult Psychiatry, Reykjavik Iceland.
  • Pola R; Vogur SAA Addiction Treatment Center, Reykjavik Iceland.
  • Lindblad B; Vogur SAA Addiction Treatment Center, Reykjavik Iceland.
  • van Rij AM; Laboratory of Vascular Biology & Genetics, A. Gemelli University Hospital,Universita Cattolica del Sacro Cuore School of Medicine, Rome, Italy.
  • Dieplinger B; Center for Vascular Diseases, University Hospital. MAS, Malmö, Sweden.
  • Haltmayer M; Department of Surgery, Dunedin School of Medicine, University of Otago, New Zealand.
  • Mayordomo JI; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
  • Kiemeney LA; Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.
  • Matthiasson SE; University Hospital, Division of Medical Oncology, Zaragoza Spain.
  • Oskarsson H; Nanotechnology Institute of Aragon, Zaragoza Spain.
Nature ; 452(7187): 638-642, 2008 Apr 03.
Article en En | MEDLINE | ID: mdl-18385739
ABSTRACT
Smoking is a leading cause of preventable death, causing about 5 million premature deaths worldwide each year. Evidence for genetic influence on smoking behaviour and nicotine dependence (ND) has prompted a search for susceptibility genes. Furthermore, assessing the impact of sequence variants on smoking-related diseases is important to public health. Smoking is the major risk factor for lung cancer (LC) and is one of the main risk factors for peripheral arterial disease (PAD). Here we identify a common variant in the nicotinic acetylcholine receptor gene cluster on chromosome 15q24 with an effect on smoking quantity, ND and the risk of two smoking-related diseases in populations of European descent. The variant has an effect on the number of cigarettes smoked per day in our sample of smokers. The same variant was associated with ND in a previous genome-wide association study that used low-quantity smokers as controls, and with a similar approach we observe a highly significant association with ND. A comparison of cases of LC and PAD with population controls each showed that the variant confers risk of LC and PAD. The findings provide a case study of a gene-environment interaction, highlighting the role of nicotine addiction in the pathology of other serious diseases.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Asunto principal: Tabaquismo / Cromosomas Humanos Par 15 / Receptores Nicotínicos / Enfermedades Vasculares Periféricas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa / Oceania Idioma: En Revista: Nature Año: 2008 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Tabaquismo / Cromosomas Humanos Par 15 / Receptores Nicotínicos / Enfermedades Vasculares Periféricas / Predisposición Genética a la Enfermedad / Polimorfismo de Nucleótido Simple / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Europa / Oceania Idioma: En Revista: Nature Año: 2008 Tipo del documento: Article